Evidence map›Paper›PMID 9596749›Full record

ArticleInfection and immunity1998

Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears.

X D Qu, R I Lehrer

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 253 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2020
    Review
  11. Review
  12. Article
  13. Immunity, microbiota and kidney disease.Nature reviews. Nephrology · 2019
    Review
  14. G.I. pros: Antimicrobial defense in the gastrointestinal tract.Seminars in cell & developmental biology · 2019
    Review
  15. Article
  16. Article
  17. Group IIA-Secreted Phospholipase AInfection and immunity · 2018
    Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

X D QuDepartment of Medicine, UCLA School of Medicine, Los Angeles, California 90095-1690, USA.
R I Lehrer
University of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
TRANSMISSION OF PNEUMOCYSTIS INFECTIONR01AI029839 · NIAID · UNIVERSITY OF CINCINNATI · PI CUSHION, MELANIE T · 1991 to 2001
$445k
NCI NIH HHS CA 16042NCI NIH HHS P30 CA016042NIAID NIH HHS AI-29839
6 · The paper itself

Abstract

We examined human tears for molecules that killed gram-positive bacteria. The principal mediator of bactericidal activity against staphylococci proved to be a calcium-dependent enzyme, secretory phospholipase A2. Whereas the concentration of secretory phospholipase A2 in the normal tear film exceeded 30 microg/ml, only 1.1 ng (<0.1 nM) of the enzyme per ml sufficed to kill Listeria monocytogenes and 15 to 80 ng/ml killed Staphylococcus aureus. Despite its efficacy against gram-positive bacteria, secretory phospholipase A2 lacked bactericidal activity against gram-negative organisms (Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa) when tested in the ionic environment of tears. Given the presence of secretory phospholipase A2 in tears, intestinal secretions, and leukocytes, this enzyme may play a substantial role in innate mucosal and systemic bactericidal defenses against gram-positive bacteria.

Indexed as

AdultAnti-Bacterial AgentsCations, DivalentEyeFemaleGram-Negative BacteriaGram-Positive BacteriaHumansLactoferrinMaleMuramidasePhospholipases APhospholipases A2StaphylococcusTearsTime FactorsAnti-Bacterial AgentsCations, DivalentLactoferrinMuramidasePhospholipases APhospholipases A2

Identifiers

PMID9596749
PMCPMC108271
OpenAlexW2144472726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.